Shame on Aesculap: A $38.5M Settlement Exposes Device Failures, Kickbacks, and Why Foreign Ortho Giants Hesitate on the U.S. Market
In a move that reeks of corporate damage control rather than genuine accountability, Aesculap Implant Systems (AIS), the Pennsylvania-based arm of German medtech giant B. Braun, announced today the resolution of long-pending federal investigations.
But let's call this what it is: a slap on the wrist disguised as closure, with AIS shelling out $38.5 million in a civil settlement under the False Claims Act, plus a non-prosecution agreement to dodge criminal charges....
